Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
PUMA BIOTECHNOLOGY, INC. has filed 1,112 SEC EDGAR filings since 14 Sep 2007

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
SC 13G/A File 005-83367

SC 13G/A filing

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

SCHEDULE 13G/A

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

PUMA BIOTECHNOLOGY, INC.

Filing date
13 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Dec 2012
Reporting date
18 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PHILLIPS F4

Filing date
18 Dec 2012
Reporting date
17 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

EYLER F4

Filing date
18 Dec 2012
Reporting date
17 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Dec 2012
Reporting date
17 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PUMA BIOTECHNOLOGY, INC. (ADAGE)

Filing date
14 Dec 2012
Reporting date
12 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Dec 2012
Reporting date
07 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-178308

PROSPECTUS SUPPLEMENT NO. 7

Filing date
14 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-83367

AMENDMENT NO.1 TO SCHEDULE 13D

Filing date
09 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

AUERBACH F4

Filing date
31 Oct 2012
Reporting date
24 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83367

SC 13G

Filing date
26 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MALLEY F4

Filing date
25 Oct 2012
Reporting date
24 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-178308

PROSPECTUS SUPPLEMENT NO.6

Filing date
24 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

FORM 8-K

Filing date
24 Oct 2012
Reporting date
18 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MALLEY F4

Filing date
22 Oct 2012
Reporting date
18 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MOYES F4

Filing date
22 Oct 2012
Reporting date
18 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Oct 2012
Reporting date
18 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B1 File 333-184187

FINAL PROSPECTUS

Filing date
19 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-184187

EFFECT filing

Filing date
18 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-184495

S-1MEF

Filing date
18 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-184187

AMENDMENT NO. 2 TO FORM S-1

Filing date
17 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERTNYS File 001-35703

AUTO-GENERATED PAPER DOCUMENT

Filing date
17 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .